| 2004N-0330 - Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee|
|FDA Comment Number :||EC32|
|Submitter :||Mrs. Eileen Davis Kovar||Date & Time:||09/16/2004 06:09:55|
|Organization :||ASPEN Ocean County Chapter|
| My 10 year old son has Asperger Syndrome, a neurobiological disorder on the Autism Spectrum. He regularly sees a pediatric psychiatrist that closely monitors his medications and adjusts them as necessary depending on his behaviors. I also closely monitor his medications and watch for any changes in his behaviors. He takes Wellbutrin for depression and Zoloft for his extreme anxiety for the past year. These two drugs taken together greatly reduce his anxiety and depression and allow him to function in a public school in a mainstream classroom setting and participate in life. Without these two medications he is very depressed and extremely anxious which causes him to withdraw from life.
I strongly believe that these medications should not be removed for use in the pediatric population. It is a case of throwing the baby out with the bath water. In the correct situations these medications do much more good than harm. If you have qualified doctors prescribing and monitoring the medications and parents working with the doctors to monitor their child at home there should be communications between them to catch problems before they occur. I believe there should be much stronger prescribing guidelines, like these medications should only be prescribed by psychiatrists and a booklet be given to parents on what changes to look for and when you should call the doctor. Pediatricians should be initially consulted if a parent is concerned that their child is depressed. The pediatrician should then refer to a psychiatrist for further evaluations including the need for medications.
Please don't eliminate these medications in the pediatric population! I'm more afraid of suicide if these children don't have their necessary medications then the medications causing suicide.
Eileen Davis Kovar